The present invention is directed to novel PRO10013 polypeptides chimeric polypeptide molecules comprising PRO10013 polypeptides fused to heterologous polypeptide sequences.

 
Web www.patentalert.com

< Anti-cancer antibodies with reduced complement fixation

> Secreted and transmembrane polypeptides and nucleic acids encoding the same
~ 00448